1. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974. 2:1279–1283.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998. 15:539–553.
3. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med. 2000. 32:539–543.
4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med. 2000. 342:301–307.
5. Imagawa A, Hanafusa T. Pathogenesis of fulminant type 1 diabetes. Rev Diabet Stud. 2006. 3:169–177.
6. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003. 26:2345–2352.
7. Sano H, Terasaki J, Tsutsumi C, Imagawa A, Hanafusa T. A case of fulminant type 1 diabetes mellitus after influenza B infection. Diabetes Res Clin Pract. 2008. 79:e8–e9.
8. Goto A, Takahashi Y, Kishimoto M, Nakajima Y, Nakanishi K, Kajio H, Noda M. A case of fulminant type 1 diabetes associated with significant elevation of mumps titers. Endocr J. 2008. 55:561–564.
9. Kwon JY, Roh MO, Song MS, Jung CH, Park HK, Kim YJ, Mok JO, Kim SJ, Kim CH, Byun DW, Yu MH, Suh KI, Jung JH. A case of fulminant type 1 diabetes mellitus after hepatitis A infection. Korean Clin Diabetes. 2009. 10:118–122.
10. Akatsuka H, Yano Y, Gabazza EC, Morser J, Sasaki R, Suzuki T, Fujiwara R, Katsuki A, Takei Y, Sumida Y. A case of fulminant type 1 diabetes with coxsackie B4 virus infection diagnosed by elevated serum levels of neutralizing antibody. Diabetes Res Clin Pract. 2009. 84:e50–e52.
11. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med. 2000. 342:1835–1837.
12. Shimada A, Morimoto J, Kodama K, Oikawa Y, Irie J, Nakagawa Y, Narumi S, Saruta T. T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes. Diabetes Care. 2002. 25:635–636.
13. Shimada A, Oikawa Y, Shigihara T, Senda T, Kodama K. A case of fulminant type 1 diabetes with strong evidence of autoimmunity. Diabetes Care. 2002. 25:1482–1483.
14. Miura Y, Suzuki A, Sato I, Kato Y, Oiso Y. A case of fulminant type 1 diabetes with graves' disease. Diabetes Care. 2002. 25:1894–1895.
15. Sakaue S, Nagata M, Wakabayashi O, Honda T, Yoshimura H, Yamaguchi E, Nishimura M. A case of fulminant type 1 diabetes with elevated rheumatoid factor and the temporal presence of thyroid-stimulating hormone receptor antibody. Diabetes Care. 2002. 25:935–936.
16. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia. 2005. 48:294–300.
17. Taniyama M, Katsumata R, Aoki K, Suzuki S. A Filipino patient with fulminant type 1 diabetes. Diabetes Care. 2004. 27:842–843.
18. Zheng C, Zhou Z, Yang L, Lin J, Huang G, Li X, Zhou W, Wang X, Liu Z. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese. Diabetes Metab Res Rev. 2011. 27:70–78.
19. Jung TS, Chung SI, Kim MA, Kim SJ, Park MH, Kim DR, Kang MY, Hahm JR. A Korean patient with fulminant autoantibody-negative type 1 diabetes. Diabetes Care. 2004. 27:3023–3024.
20. Kim MS, Yu KY, Lee SY, Kim SY, Kim SJ, Hwang PH, Lee DY. A case of fulminant type 1 diabetes mellitus with peripheral neuropathy in a Korean child. J Korean Soc Pediatr Endocrinol. 2009. 14:82–84.